Filing Details

Accession Number:
0001104659-14-000347
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-03 16:02:25
Reporting Period:
2014-01-02
Filing Date:
2014-01-03
Accepted Time:
2014-01-03 16:02:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1463729 Receptos Inc. RCPT Pharmaceutical Preparations (2834) 264190792
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1205903 H William Rastetter C/O Receptos, Inc.
10835 Road To The Cure, Suite 205
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-01-02 27,581 $30.29 1,305,180 No 4 S Indirect By Funds
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Funds
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 332,234 Indirect By Trust
Footnotes
  1. Disposition of shares by the Venrock entities. Beneficial ownership by the Venrock entities consists of: (i) 1,177,667 shares of common stock held by Venrock Associates V, L.P. ("Venrock Associates"); (ii) 99,845 shares of common stock held by Venrock Partners V, L.P. ("Venrock Partners"); and (iii) 27,668 shares of common stock held by Venrock Entrepreneurs Fund V, L.P. ("Venrock Entrepreneurs").
  2. The sole general partner of Venrock Associates is Venrock Management V, LLC ("VM5"). The sole general partner of Venrock Partners is Venrock Partners Management V, LLC ("VPM5"). The sole general partner of Venrock Entrepreneurs is VEF Management V, LLC ("VEF"). VM5, VPM5 and VEF disclaim beneficial ownership over all shares held by Venrock Associates, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interest therein. Dr. Rastetter was formerly a consultant of an entity affiliated with the Venrock entities but does not have voting or investment control over the shares held by the Venrock entities. Dr. Rastetter has an indirect pecuniary interest in the investment held by the Venrock entities and expressly disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.